Spots Global Cancer Trial Database for mycophenolate mofetil (mmf)

Every month we try and update this database with for mycophenolate mofetil (mmf) cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Study title	NCT ID	Conditions	Interventions	Eligibility	Organization
Vorinostat for Graft vs Host Disease Prevention in Children, Adolescents and Young Adults Undergoing Allogeneic Blood and Marrow Transplantation	NCT03842696	Hematologic Dis... Acute Leukemia ... Chronic Myeloge... Chronic Myeloge... Chronic Myeloge... Myelodysplastic... Mantle Cell Lym... Follicular Lymp... Diffuse Large B... Non Hodgkin Lym... Graft Vs Host D... Graft-versus-ho...	Vorinostat Blood and Marro... Tacrolimus (or ... Methotrexate Mycophenolate M... Cyclophosphamid...	3 Years - 39 Years	University of Michigan Rogel Cancer Center
Sirolimus & Mycophenolate Mofetil as GvHD Prophylaxis in Myeloablative, Matched Related Donor HCT	NCT01220297	Hematologic Dis... Acute-graft-ver... Leukemia Non-Hodgkin Lym... Hodgkin Lymphom...	Sirolimus Mycophenolate m... Carmustine Etoposide Cyclophosphamid... FTBI	2 Years - 60 Years	Stanford University
Safety and Efficacy of Pentostatin and Low Dose TBI With Allogenic Peripheral Blood Stem Cell Transplant	NCT00571662	Acute Myelogeno... Acute Lymphocyt... Chronic Myeloge... Chronic Lymphoc... Myelodysplastic... Multiple Myelom... Non-Hodgkins Ly... Hodgkins Diseas... Peripheral T-ce...	Pentostatin Total-body irra... Cyclosporine A ... Mycophenolate M... G-CSF	19 Years - 75 Years	University of Nebraska
A Two-Step Approach to Bone Marrow Transplant Using Cells From A Partially-Matched Relative	NCT00429143	Hematologic Mal...	Total Body Irra... Donor Lymphocyt... Cyclophosphamid... Tacrolimus Mycophenolate M... Hematopoietic S...	18 Years -	Thomas Jefferson University
Allogeneic HCT Using Nonmyeloablative Host Conditioning With TLI & ATG vs SOC in AML	NCT00568633	Leukemia, Myelo... Leukemia Acute Myeloid L...	Allogeneic HSCT Anti-thymocyte ... Cyclosporine (C... Mycophenolate m... Total lymphoid ... Methylprednisol... Best standard c...	50 Years - 75 Years	Stanford University
Infusion of Expanded Cord Blood T Cells	NCT00972101	Stem Cell Trans... Leukemia Lymphoma Pediatric Disor...	Total Body Irra... Melphalan Thiotepa Fludarabine Rituximab Etoposide Anti-thymocyte ... Mycophenolate M... Tacrolimus Cord Blood Infu... G-CSF Ex vivo expande...	- 55 Years	M.D. Anderson Cancer Center
Total Body Irradiation +/- Total Lymphoid Irradiation & Anti-Thymocyte Globulin in Non-myeloablative Hematopoietic Cell Transplantation	NCT03734601	Acute Myeloid L... Myelodysplastic... Myeloproliferat... Chronic Lymphoc... B-cell Lymphoma T-cell Lymphoma Non Hodgkin Lym... Hodgkin Lymphom... Chronic Myelomo...	Total body irra... Anti-thymocyte ... Tacrolimus Mycophenolate m... Total lymphoid ...	18 Years -	Stanford University
Bone Marrow Transplantation of Patients in Remission Using Partially Matched Relative Donor	NCT01350245	Acute Myeloid L... Myelodysplastic... Biphenotypic Le... Acute Lymphocyt... Chronic Myeloid... Chronic Lymphoc... Plasma Cell Neo... Lymphoma Hodgkin's Disea... Aplastic Anemia	Total Body Irra... Donor Lymphocyt... Cyclophosphamid... Mycophenolate M... Tacrolimus Hematopoietic s...	18 Years -	Thomas Jefferson University
Allogeneic Transplantation Using Total Lymphoid Irradiation (TLI) and Anti-Thymocyte Globulin (ATG) for Older Patients With Hematologic Malignancies	NCT00185640	Blood Cancer Leukemia	Cyclosporine Anti-thymocyte ... Mycophenolate m... Filgrastim Total Lymphoid ...	50 Years - 70 Years	Stanford University
Cord Blood Transplant in Adults With Blood Cancers	NCT05884333	Acute Myelogeno... Acute Lymphobla... Chronic Myeloge... Myelodysplastic... Myeloproliferat... Non-Hodgkin's L...	Conditioning Ch... Cord blood graf...	21 Years - 65 Years	Memorial Sloan Kettering Cancer Center
Total Body Irradiation +/- Total Lymphoid Irradiation & Anti-Thymocyte Globulin in Non-myeloablative Hematopoietic Cell Transplantation	NCT03734601	Acute Myeloid L... Myelodysplastic... Myeloproliferat... Chronic Lymphoc... B-cell Lymphoma T-cell Lymphoma Non Hodgkin Lym... Hodgkin Lymphom... Chronic Myelomo...	Total body irra... Anti-thymocyte ... Tacrolimus Mycophenolate m... Total lymphoid ...	18 Years -	Stanford University
Cord Blood Transplant in Adults With Blood Cancers	NCT05884333	Acute Myelogeno... Acute Lymphobla... Chronic Myeloge... Myelodysplastic... Myeloproliferat... Non-Hodgkin's L...	Conditioning Ch... Cord blood graf...	21 Years - 65 Years	Memorial Sloan Kettering Cancer Center
Conditioning Regimen and the Transplantation of Unrelated Donor Umbilical Cord Blood in Patients With Hematologic Malignancies.	NCT00739141	Leukemia Myelodysplastic... Non-Hodgkins Ly... Chronic Myeloge... Hodgkins Lympho...	fludarabine, cy...	18 Years - 70 Years	Memorial Sloan Kettering Cancer Center
Safety and Efficacy of Pentostatin and Low Dose TBI With Allogenic Peripheral Blood Stem Cell Transplant	NCT00571662	Acute Myelogeno... Acute Lymphocyt... Chronic Myeloge... Chronic Lymphoc... Myelodysplastic... Multiple Myelom... Non-Hodgkins Ly... Hodgkins Diseas... Peripheral T-ce...	Pentostatin Total-body irra... Cyclosporine A ... Mycophenolate M... G-CSF	19 Years - 75 Years	University of Nebraska
Allogeneic Transplantation Using Total Lymphoid Irradiation (TLI) and Anti-Thymocyte Globulin (ATG) for Older Patients With Hematologic Malignancies	NCT00185640	Blood Cancer Leukemia	Cyclosporine Anti-thymocyte ... Mycophenolate m... Filgrastim Total Lymphoid ...	50 Years - 70 Years	Stanford University
Vorinostat for Graft vs Host Disease Prevention in Children, Adolescents and Young Adults Undergoing Allogeneic Blood and Marrow Transplantation	NCT03842696	Hematologic Dis... Acute Leukemia ... Chronic Myeloge... Chronic Myeloge... Chronic Myeloge... Myelodysplastic... Mantle Cell Lym... Follicular Lymp... Diffuse Large B... Non Hodgkin Lym... Graft Vs Host D... Graft-versus-ho...	Vorinostat Blood and Marro... Tacrolimus (or ... Methotrexate Mycophenolate M... Cyclophosphamid...	3 Years - 39 Years	University of Michigan Rogel Cancer Center
Allogeneic HCT Using Nonmyeloablative Host Conditioning With TLI & ATG vs SOC in AML	NCT00568633	Leukemia, Myelo... Leukemia Acute Myeloid L...	Allogeneic HSCT Anti-thymocyte ... Cyclosporine (C... Mycophenolate m... Total lymphoid ... Methylprednisol... Best standard c...	50 Years - 75 Years	Stanford University
Pilot Study of Unrelated Cord Blood Transplantation	NCT00916045	Leukemia, Myelo... Myelodysplastic... Leukemia, Lymph... Lymphoma, Non-H... Hodgkin Disease Chronic Lymphoc...	Thiotepa Fludarabine Intravenous bus... Thymoglobulin Ciclosporin Mycophenolate m... Fludarabine Cyclophosphamid... Radiotherapy Thymoglobulin Ciclosporin Mycophenolate m... Fludarabine Melphalan Thymoglobulin Ciclosporin Mycophenolate m...	18 Years - 70 Years	King's College Hospital NHS Trust
Reduced Intensity Allogeneic HCT in Advanced Hematologic Malignancies w/T-Cell Depleted Graft	NCT05088356	Allogeneic Hema... Advanced Hemato... Acute Leukemia Chronic Myeloge... Myelodysplastic... Myeloproliferat...	Purified regula... Fludarabine Melphalan CliniMACS CD34 ... Tacrolimus Cyclophosphamid... Plerixafor Filgrastim gran... Thiotepa Mycophenolate M... Ruxolitinib	18 Years - 75 Years	Stanford University
Total Body Irradiation +/- Total Lymphoid Irradiation & Anti-Thymocyte Globulin in Non-myeloablative Hematopoietic Cell Transplantation	NCT03734601	Acute Myeloid L... Myelodysplastic... Myeloproliferat... Chronic Lymphoc... B-cell Lymphoma T-cell Lymphoma Non Hodgkin Lym... Hodgkin Lymphom... Chronic Myelomo...	Total body irra... Anti-thymocyte ... Tacrolimus Mycophenolate m... Total lymphoid ...	18 Years -	Stanford University
Phase 2 Poor Risk DLBCL of TLI and ATG Followed by Matched Allogeneic HT as Consolidation to Autologous HCT	NCT00482053	Lymphoma, B-cel... Lymphoma, Non-H... Diffuse Large B... Malignant Lymph...	Autologous hema... Allogeneic hema... Total lymphoid ... Rituximab Carmustine Etoposide Filgrastim Anti-thymocyte ... Cyclosporine Mycophenolate m... Cyclophosphamid... Acetaminophen Diphenhydramine Hydrocortisone Methylprednisol...	18 Years - 70 Years	Stanford University
Infusion of Expanded Cord Blood T Cells	NCT00972101	Stem Cell Trans... Leukemia Lymphoma Pediatric Disor...	Total Body Irra... Melphalan Thiotepa Fludarabine Rituximab Etoposide Anti-thymocyte ... Mycophenolate M... Tacrolimus Cord Blood Infu... G-CSF Ex vivo expande...	- 55 Years	M.D. Anderson Cancer Center
Infusion of Expanded Cord Blood T Cells	NCT00972101	Stem Cell Trans... Leukemia Lymphoma Pediatric Disor...	Total Body Irra... Melphalan Thiotepa Fludarabine Rituximab Etoposide Anti-thymocyte ... Mycophenolate M... Tacrolimus Cord Blood Infu... G-CSF Ex vivo expande...	- 55 Years	M.D. Anderson Cancer Center
Cord Blood With T-Cell Depleted Haplo-identical Peripheral Blood Stem Cell Transplantation for Hematological Malignancies	NCT01682226	Leukemia Myelodysplastic... Lymphoma	CliniMACS Fract... CliniMACS Fract... Haploidentical ...	2 Years - 70 Years	Memorial Sloan Kettering Cancer Center

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

Join others from around the world: